Driehaus Capital Management LLC Kura Oncology, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $6.54 Million - $10.3 Million	-264,295 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $7.66 Million - $11 Million	264,295 New	264,295 $8.63 Million
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $238,500 - $564,300	-30,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $64,500 - $140,400	-10,000 Reduced 25.0%	30,000 $299,000
Q4 2019 Feb 12, 2020	SELL	$12.97 - $15.94 $5.52 Million - $6.78 Million	-425,588 Reduced 91.41%	40,000 $550,000
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $1.59 Million - $2.25 Million	107,656 Added 30.08%	465,588 $7.06 Million
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $5.27 Million - $7.08 Million	357,932 New	357,932 $7.05 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.